|
|
-
Thursday, July 31, 2025
5:16:01 AM
|
|
 |
|
Vinmec's Innovations Spotlighted at Global CSR & ESG Summit 2024 May 09, 2024 05:04 HKT |  | | Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea May 08, 2024 09:00 HKT |  | | CanSinoBIO CSO Shares Latest Results of the Company's Globally Innovative Pneumococcal Vaccine Apr 26, 2024 15:36 HKT |  | | Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25 Apr 19, 2024 16:00 HKT |  | | Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study Mar 28, 2024 14:42 HKT |  | | Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1% Mar 18, 2024 21:30 HKT |  | | LYC Healthcare Reports Strong Q3 FY2024 Results of RM36.0 Million Feb 28, 2024 09:34 HKT |  | | Avance Clinical CEO Talks with SCRIP about US Biotech Sector "Green Shoots" and a New CRO Report Feb 28, 2024 08:00 HKT |  | | Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner Jan 12, 2024 16:00 HKT |  | | Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US Oct 19, 2023 09:00 HKT |  | | HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies Aug 28, 2023 19:30 HKT |  | | WholisticResearch Reveals the Best Nootropics of 2023 Aug 18, 2023 06:00 HKT |  | | Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics Aug 17, 2023 21:00 HKT |  | | Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22% Aug 16, 2023 19:06 HKT |  | | The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed Jul 26, 2023 18:58 HKT |  | | HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies Jul 24, 2023 19:30 HKT |  | | RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP) Platform Jul 20, 2023 16:00 HKT |  | | ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK Jun 30, 2023 14:25 HKT |  | | ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share Jun 19, 2023 11:37 HKT |  | | Asensus Shares First Quarter Results and Future Plans Jun 01, 2023 21:40 HKT |  | |
<< Previous
Next >>
|
|
|
Copyright © 2025 ACN Newswire - Asia Corporate News Network |
|
Connect With us:
|
|